Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / P••••• I•••••••••

W•••••• P••••• Announces Acquisition Of P••••• I••••••••• From I•••••• Feb 10, 2022

Platform acquisitionannouncedannounced Feb 10, 2022Fact
What happened
Target
P••••• I•••••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / life sciences, pharma
Target location
unknown
Seller kind
Unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • C••••••• R••••Deal partnerconfirmed
    “Adarsh Sarma, co-head of Europe and C••••••• R••••, Head of Strategic Investments at W•••••• P••••• said ‘’P••••• I••••••••• is an increasingly important company with tremendous growth potential.”
  • W•••••• P••••• L••Sponsorconfirmed
    “W•••••• P•••••, a leading global growth investor, today announced the acquisition of P••••• I•••••••••, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from I•••••• P•• (LSE:INF.L), the international B2B markets know”
Sell side
  • I•••••• P••Sellerconfirmed
    “W•••••• P•••••, a leading global growth investor, today announced the acquisition of P••••• I•••••••••, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from I•••••• P•• (LSE:INF.L), the international B2B markets know”
Side not stated
  • A•• K••••••Managementconfirmed
    “David Reis and A•• K••••••, Managing Directors at W•••••• P••••• said "”
  • P••••• I•••••••••Targetconfirmed
    “W•••••• P•••••, a leading global growth investor, today announced the acquisition of P••••• I•••••••••, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from I•••••• P•• (LSE:INF.L), the international B2B markets know”
Evidence
“W•••••• P•••••, a leading global growth investor, today announced the acquisition of P••••• I•••••••••, a leading provider of specialist intelligence, data, and software for clinical trials, drug development, and regulatory compliance, from I•••••• P•• (LSE:INF.L), the international B2B markets knowledge services and business intelligence group.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026